Vyhledávat v databázi titulů je možné dle ISBN, ISSN, EAN, č. ČNB, OCLC či vlastního identifikátoru. Vyhledávat lze i v databázi autorů dle id autority či jména.

Projekt ObalkyKnih.cz sdružuje různé zdroje informací o knížkách do jedné, snadno použitelné webové služby. Naše databáze v tuto chvíli obsahuje 2613812 obálek a 779782 obsahů českých a zahraničních publikací. Naše API využívá většina knihoven v ČR.

Registrovat »    Zapomenuté heslo?

Jaffe, Elaine Sarkin

Nahlásit porušení duševního vlastnictví, nebo práva na ochranu soukromí.

Autor: Jaffe, Elaine Sarkin
Rok: 1943-

Biogr./Hist. údaje: Americká lékařka, hematopatoložka.
Zdroj: Autoritní databáze Národní knihovny ČR

Elaine Sarkin Jaffe

Elain Sarkin Jaffe is a senior National Cancer Institute (NCI) investigator at the National Institutes of Health (NIH). She completed her medical education at Cornell University and the University of Pennsylvania, receiving her M.D. from University of Pennsylvania in 1969. After an internship at Georgetown University she joined NCI as a resident anatomic pathology, and has been a senior investigator since 1974, focusing on the classification and definition of lymphoid neoplasms. Jaffe's early work helped to provide a much more depth understanding of the origin of lymphomas, particular her work in follicular lymphomas. Her team notably elucidated the difference between T cell and B cell lymphomas.Her lab's findings led to the development of the WHO Classification of Tumours of the Hematopoetic and Lymphoid Tissues. Jaffe was the President of the Society of Hematopathology at the time that the WHO's Revised European-American Classification of Lymphoid Neoplasms (REAL) classification system was developed in 1994; the REAL classification system is now considered the gold standard in hematopathology. Today, her research includes genetic and epigenetic studies aimed at understanding how B-cells become Hodgkins lymphoma cells, particularly through the lens of the microenvironment. Jaffe's research has led to improvements in cancer treatments, including disease-specific therapies and improved clinical outcomes.

Pro přidání, nebo úpravu fotografie autora se prosím přihlaste: